GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (LTS:0I0L) » Definitions » EV-to-Revenue

Labo Euromedis (LTS:0I0L) EV-to-Revenue : 0.12 (As of Jun. 03, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Labo Euromedis EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Labo Euromedis's enterprise value is €3.99 Mil. Labo Euromedis's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €34.00 Mil. Therefore, Labo Euromedis's EV-to-Revenue for today is 0.12.

The historical rank and industry rank for Labo Euromedis's EV-to-Revenue or its related term are showing as below:

LTS:0I0L' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.02   Med: 0.39   Max: 0.93
Current: 0.12

During the past 14 years, the highest EV-to-Revenue of Labo Euromedis was 0.93. The lowest was -0.02. And the median was 0.39.

LTS:0I0L's EV-to-Revenue is ranked better than
95.9% of 829 companies
in the Medical Devices & Instruments industry
Industry Median: 3.19 vs LTS:0I0L: 0.12

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-03), Labo Euromedis's stock price is €4.11032. Labo Euromedis's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €11.71. Therefore, Labo Euromedis's PS Ratio for today is 0.35.


Labo Euromedis EV-to-Revenue Historical Data

The historical data trend for Labo Euromedis's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis EV-to-Revenue Chart

Labo Euromedis Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.22 0.14 0.01 1.12

Labo Euromedis Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 - 0.01 - -

Competitive Comparison of Labo Euromedis's EV-to-Revenue

For the Medical Devices subindustry, Labo Euromedis's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labo Euromedis's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Labo Euromedis's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Labo Euromedis's EV-to-Revenue falls into.



Labo Euromedis EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Labo Euromedis's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3.994/34
=0.12

Labo Euromedis's current Enterprise Value is €3.99 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labo Euromedis's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was €34.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis  (LTS:0I0L) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Labo Euromedis's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=4.11032/11.713
=0.35

Labo Euromedis's share price for today is €4.11032.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was €11.71.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Labo Euromedis (LTS:0I0L) Business Description

Traded in Other Exchanges
Address
ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (LTS:0I0L) Headlines

No Headlines